Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,899 | 116,678 | 189,576 | 143,663 | 89,798 |
| Marketable Securities | 413 | N/A | N/A | N/A | N/A |
| Receivables | 229 | 901 | 720 | 488 | 10,000 |
| Other current assets | 2,007 | 12,803 | 2,784 | 169 | 4 |
| TOTAL | $94,989 | $136,359 | $199,105 | $161,754 | $105,564 |
| Non-Current Assets | |||||
| PPE Net | 3,089 | 6,338 | 11,815 | 25,154 | 35,090 |
| Investments And Advances | 3,206 | 3,206 | 4,748 | 6,842 | 0 |
| Intangibles | 622 | 400 | 731 | 2,048 | 1,373 |
| Other Non-Current Assets | 34,482 | 13,478 | 21,770 | 15,700 | 8,131 |
| TOTAL | $41,399 | $23,422 | $39,064 | $49,744 | $44,594 |
| Total Assets | $136,388 | $159,781 | $238,169 | $211,498 | $150,158 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,312 | 25,380 | 653 | 1,144 | 792 |
| Accrued Expenses | 7,198 | 6,535 | 6,931 | 10,793 | 9,014 |
| Other current liabilities | 989 | 2,391 | 745 | 977 | 854 |
| TOTAL | $14,980 | $49,987 | $59,664 | $35,980 | $42,829 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,321 | N/A | 22,223 | 2,478 | N/A |
| Deferred Revenues | 2,957 | 12,035 | 46,192 | 21,244 | 30,236 |
| Other Non-Current Liabilities | 19,394 | 17,851 | 12,977 | 14,857 | 8,978 |
| TOTAL | $65,015 | $90,933 | $118,072 | $84,350 | $62,904 |
| Total Liabilities | $79,995 | $140,920 | $177,736 | $120,330 | $105,733 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,482 | 6,916 | 3,706 | 2,033 | 1,898 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -482,464 | -489,631 | -428,312 | -316,675 | -286,073 |
| Other shareholders' equity | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $56,393 | $18,861 | $60,433 | $91,168 | $44,425 |
| Total Liabilities And Equity | $136,388 | $159,781 | $238,169 | $211,498 | $150,158 |